Globally, the size of the Digital PCR and qPCR Market accounted for USD 3.92 billion in 2019. It is expected to grow at a rate of 8.96% and is predicted to around USD 6.12 billion by 2025.
Polymerase Chain Reaction (PCR) is an analytical process very extensively used in Molecular Biology to make multiple copies of DNA segments. PCR can generate millions of copies from one DNA segment.
The increasing adoption rate of real-time PCR and digital PCR for diagnosing genetic disorders and other infectious diseases such as tuberculosis, malaria, and others, is a major contributing factor for the growth of the global digital PCR and qPCR market during the review period. Increasing the focus of government and private organizations to develop novel and innovative digital PCR and qPCR products is boosting the growth of the global market. The emergence of innovative and advanced genomic analysis products across the world is another major factor that is fueling up the growth rate of the digital PCR and qPCR market. Digital PCR and qPCR devices are highly efficient for estimating disease-causing microbes, and analysis of diagnostics and this is fueling the growth of the global digital PCR and qPCR market.
Increasing expenditure of healthcare and emerging economies of the countries like U.S, China, Canada, India, U.K, Japan, and other developed and developing countries across the world owing to rise in incidence of genetic disorders and other chronic diseases such as cancer, and technological advancements are anticipated to create lucrative opportunities for the market players in the region during the forecast period. Benefits offered by digital PCR over traditional PCR such as accuracy, better sensitivity, enhanced flexibility are supposed to expand growth opportunities for the global digital PCR and qPCR market during the forecast period. Increasing applications of the qPCR consumables and reagents and other clinical applications are assumed to offer growth opportunities for the growth of this market.
In recent years the increasing demand for fast diagnostics, decrepit population, infectious and genetic disorders such as cancer, HIV, Hepatitis are some of the pushing factors for the Digital PCR and qPCR Market growth. Rapid technological advancements are also one reason that has recently attracted investments in the market, but still, a lot of growth is expected in the Global Digital PCR and qPCR Market.
However, technical glitches and the high initial cost of the dPCR & qPCR is a pulling force for the market. Another primary factor that is limiting the growth of the digital PCR and qPCR market is the high costs associated with the instruments, need for capital investments on a large scale to develop advanced devices. Technical limitations related to PCR are also controlling the adoption rate, which is another major factor challenging the growth of the global digital PCR and qPCR business.
Key Happenings in this market in the recent past:
REPORT COVERAGE:
|
REPORT METRIC |
DETAILS |
|
Market Size Available |
2019 – 2025 |
|
Base Year |
2019 |
|
Forecast Period |
2020 - 2025 |
|
Segments Covered |
By Product, Technology, Application, End-User and Region |
|
Various Analyses Covered |
Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities |
|
Regions Covered |
North America, Europe, APAC, Latin America, Middle East & Africa |
|
Market Leaders Profiled |
Thermo Fisher Scientific Inc., F Hoffman-La Roche Ltd., Bio-Rad Laboratories, Qiagen N.V., Taraka Bio Inc., Affymetrix Inc., Agilent Technologies Inc., Fluidigm Corporation, Danaher Corporation, and Becton & Dickson Company. |
This research report on the Global Digital PCR and qPCR Market segmented and sub-segmented into the following categories and analyzed market size and forecast for each segment until 2025.
Digital PCR and qPCR Market Analysis – By Product:
On the basis of product, the consumables and reagents segment is dominating the global market and is contributing the largest share of revenues to the global digital PCR and qPCR market and is expected to continue the trend during the forecast period owing to factors such as increased applications of qPCR reagents such assay kits and master mixes, and increasing investments from private and public organizations.
Digital PCR and qPCR Market Analysis – By Technology:
Digital PCR and qPCR Market Analysis – By Application:
Digital PCR and qPCR Market Analysis – By End User:
On the basis of end-user, the Hospitals and diagnostic labs are contributing a significant share of revenues to the digital PCR and qPCR market and are foreseen to be snowballing at a high pace during the forecast period.
Regional Analysis:
Among them, North America is the leading market shareholder followed by Europe and the Asia Pacific due to advance technological developments and private sector investments in these regions.
List of key market participants leading the Global Digital PCR and qPCR Market profiled in this report are:
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product
5.1.1 Introduction
5.1.1 Consumables & Reagents
5..3 Instruments
5.1.4 Y-o-Y Growth Analysis, BY Product
5.1.5 Market Attractiveness Analysis, By Product
5.1.6 Market Share Analysis, By Produt
5.2 Technology
5.2.1 Introduction
5.2.2 Quantitative PCR
5.2.3 Digital PCR
5.2.3 Y-o-Y Growth Analysis, By Technology
5.2.4 Market Attractiveness Analysis, By Technology
5.2.5 Market Share Analysis, By Technology
5.3 Application
5.3.1 Introduction
5.3.2 Tumor
5.3.2 Blood Testing
5.3.3 Pathogen Detection
5.3.4 Research & Forensic
5.3.5 Y-o-Y Growth Analysis, By Application
5.3.6 Market Attractiveness Analysis, By Application
5.3.7 Market Share Analysis, By Application
5.4 End User
5.4.1 Introduction
5.4.2 Hospitals
5.4.3 Research & Forensic centers
5.4.4 Pharmaceutical & Biotechnological centers
5.4.5 Academic Centers
5.4.6 Y-o-Y Growth Analysis, By End User
5.4.7 Market Attractiveness Analysis, By End User
5.4.8 Market Share Analysis, By End User
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product
6.1.3.3 By Technology
6.1.3.4 By Application
6.1.3.5 By End User
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product
6.1.4.3 By Technology
6.1.4.4 By Application
6.1.4.5 By End User
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product
6.1.5.3 By Technology
6.1.5.4 By Application
6.1.5.5 By End User
6.2 North America
6.1.1 Introduction
6.1.2 United States
6.1.3 Canada
6.3 Europe
6.2.1 Introduction
6.2.2 U.K
6.2.3 Spain
6.2.4 Germany
6.2.5 Italy
6.2.6 France
6.4 Asia-Pacific
6.3.1 Introduction
6.3.2 China
6.3.3 India
6.3.4 Japan
6.3.5 Australia
6.3.6 South Korea
6.5 Latin America
6.4.1 Introduction
6.4.2 Brazil
6.4.3 Argentina
6.4.4 Mexico
6.4.5 Rest of Latin America
6.6 Middle East & Africa
6.5.1 Introduction
6.5.2 Middle-East
6.5.3 Africa
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Thermo Fisher Scientific Inc.
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 F Hoffman -La Roche Inc.
8.3 Bio-Rad Laboratories
8.4 Qiagen N.V.
8.5 Taraka Bio Inc.
8.6 Affymetrix Inc.
8.7 Agilent Technologies Inc.
8.8 Fluidigm Corporation
8.9 Danaher Corporation
8.10 Bector & Dickson Company
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Feb 2020
Download Sample
Feb 2020
Download Sample
Feb 2020
Download Sample
Feb 2020
Download Sample
